Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Benzocaine Gel Toothache Dose-Response Study

ClinicalTrials.gov ID: NCT00474175

Public ClinicalTrials.gov record NCT00474175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of benzocaine gel products for the relief of toothache and to assess the subject's compliance with proposed label directions.

Study identification

NCT ID
NCT00474175
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
577 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2007 (Type not available)
Primary completion
Dec 2010 (Actual)
Completion
Dec 2010 (Actual)
Last update posted
Feb 28, 2013

2007 – 2010

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Pfizer Investigational Site Baltimore Maryland 21201 —
Pfizer Investigational Site Boston Massachusetts 02111-1527 —
Pfizer Investigational Site Detroit Michigan 48207 —
Pfizer Investigational Site Buffalo New York 14214-3008 —
Pfizer Investigational Site New York New York 10010 —
Pfizer Investigational Site Columbus Ohio 43205-2696 —
Pfizer Investigational Site Philadelphia Pennsylvania 19104-6030 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15261-0001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00474175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2013 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00474175 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →